Researchers at the University of Mississippi have developed a new dissolving microneedle system for delivering cannabidiol (CBD), with laboratory testing showing that approximately 70% of the cannabinoid was released within two hours.
The research, presented as part of the American Association of Pharmaceutical Scientists’ PharmSci 360 conference on October 27, describes a solvent-free manufacturing method designed to overcome challenges associated with conventional CBD delivery, including poor absorption and limited water solubility.
CBD is difficult to deliver consistently through oral medications because it dissolves poorly in water and undergoes substantial metabolism in the liver. The researchers developed dissolving microneedles, which are tiny projections designed to penetrate the outer layers of skin and release medication, potentially allowing CBD to bypass the digestive system.
The University of Mississippi team created microneedle arrays containing 10% CBD by weight, along with a vitamin E-derived compound that serves as a penetration enhancer and antioxidant. The formulation was manufactured using a one-step heating process at 120 degrees Celsius for 15 minutes, without requiring chemical solvents.
Laboratory testing showed that the manufacturing process preserved nearly all of the intended CBD content, with measured drug loading reaching 100.5% of the target amount. The researchers also found that the cannabinoid was successfully incorporated into an amorphous, or noncrystalline, form within the polymer matrix, a characteristic that can improve the dissolution of poorly water-soluble compounds.
The most promising formulation released approximately 70% of its CBD content within two hours under laboratory conditions while maintaining favorable mechanical properties.
Researchers said the manufacturing technique allows higher CBD loading than many conventional microneedle preparation methods, potentially making it useful for developing cannabinoid-based treatments.
The findings are preliminary and were obtained through laboratory dissolution testing rather than human or animal studies. Additional research will be needed to determine how effectively the microneedles deliver CBD through skin and whether the system provides advantages over existing formulations.
The research team concluded that the solvent-free manufacturing approach successfully produced dissolving CBD microneedles with consistent drug loading, structural integrity and controlled release characteristics.










